Moreover, G3PP association with bone metastasis development remained significant when clinical parameters (prostate-specific antigen (PSA), Pathalogical Tumor-Node-Metastasis (pTNM), and Gleason score) were included in the model (Table 3). This evidence concerns the gene KLK3 and neoplasm.